A Randomized Phase 3 Study of Tasisulam Administered as

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

A Randomized Phase 3 Study of Tasisulam Administered as Intravenous Infusion on Day 1 of a 28-Day cycle vs. Paclitaxel as Second-Line Treatment in Patients with Metastatic Melanoma
StatusFinished
Effective start/end date9/30/0911/30/12

Funding

  • Eli Lilly and Company

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.